Neuland Labs.

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE794A01010
NSEID: NEULANDLAB
BSEID: 524558
View on NSE | View on BSE

INR

22,843.55

1343.6 (6.25%)

BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 3.27 lacs

{
  "main_header": {
    "sid": 229993,
    "name": "Neuland Labs.",
    "stock_name": "Neuland Labs.",
    "full_name": "Neuland Laboratories Ltd",
    "name_url": "stocks-analysis/neuland-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "22,843.55",
    "chg": 1343.6,
    "chgp": "6.25%",
    "dir": 1,
    "prev_price": "21,499.95",
    "mcapval": "27,967.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524558,
    "symbol": "NEULANDLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE794A01010",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "20:03 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "3.27 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/neuland-labs-229993-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Neuland Laboratories Surges 19.80%: 5 Key Drivers Behind the Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-surges-1980-5-key-drivers-behind-the-rally-4144209",
        "imagepath": "",
        "date": "2026-08-09 13:00:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>3 Aug:</strong> Stock opens strong at Rs.19,610.60 (+2.85%)</p>\n                    <p><strong>5 Aug:</strong> New 52-week and all-time high at Rs.20,052; spectacular Q1 FY27 results announced</p>\n                    <p><strong>6 Aug:</strong> Hits new 52-week and all-time high of Rs.21,850 with a 7.95% surge and gap up opening</p>\n                    <p><strong>7 Aug:</strong> Reaches new 52-week high of Rs.22,499.95, closing at Rs.22,843.55 (+6.25%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.19,067.60</div></div>\n                    <div class=\"st..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Neuland Laboratories Ltd to 52-Week High of Rs 22499.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-new-52-week-high-at-rs-2249995-4141921",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NeulandLaborato_priceRelatedfactors_4141921.png",
        "date": "2026-08-07 12:35:11",
        "description": "Surging past its previous peaks, Neuland Laboratories Ltd touched an all-time high of Rs 22,499.95 on 7 Aug 2026, marking a remarkable 74.61% gain over the past year. This rally is underpinned by a confluence of strong technical indicators and sustained price momentum, even as the broader Sensex trades lower."
      },
      {
        "title": "Neuland Laboratories Ltd Hits All-Time High of Rs 22,447 as Momentum Builds Across Timeframes",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-all-time-high-amid-robust-financial-performance-4141916",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NeulandLaborato_priceRelatedfactors_4141916.png",
        "date": "2026-08-07 12:15:44",
        "description": ""
      },
      {
        "title": "Neuland Laboratories Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/neuland-laboratories-ltd-is-rated-buy-4141753",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NeulandLaborato_mojoScore_4141753.png",
        "date": "2026-08-07 10:10:03",
        "description": "Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "Are Neuland Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-neuland-laboratories-ltd-latest-results-good-or-bad-4140351",
        "imagepath": "",
        "date": "2026-08-06 19:21:15",
        "description": "Neuland Laboratories Ltd's latest financial results for Q1 FY27 reflect a complex operational landscape. The company reported net sales of ₹641.58 crores, marking a significant year-on-year growth of 119.16% from a low base in Q1 FY26. However, this growth is tempered by a sequential decline of 17.35% from the previous quarter, indicating volatility in revenue generation. \n\nNet profit for the quarter stood at ₹147.67 crores, which represents an impressive year-on-year increase of 962.37%. Nevertheless, this figure also reflects a decrease of 30.56% compared to Q4 FY26, raising questions about the sustainability of such high profitability levels. The operating margin for Q1 FY27 was reported at 34.74%, a substantial increase from 11.78% in the same quarter last year, but a decline from 39.59% in the prior quarter, suggesting challenges in maintaining margin levels.\n\nThe company's return on equity (ROE) is no..."
      },
      {
        "title": "Neuland Laboratories Ltd Surges on High-Value Trading and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-surges-on-high-value-trading-and-institutional-interest-4139745",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NeulandLaborato_most_active_equities_by_value_4139745.png",
        "date": "2026-08-06 10:00:08",
        "description": "Neuland Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 6 August 2026, driven by substantial value turnover and heightened institutional participation. The stock outperformed its sector peers and broader market indices, reflecting renewed investor confidence and robust market dynamics."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Neuland Laboratories Ltd to 52-Week High of Rs 21850",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-new-52-week-high-of-rs21850-4139852",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NeulandLaborato_priceRelatedfactors_4139852.png",
        "date": "2026-08-06 09:54:45",
        "description": "Surging past its previous peaks, Neuland Laboratories Ltd touched a new 52-week high of Rs 21,850 on 6 Aug 2026, propelled by a confluence of robust technical indicators and sustained price momentum that has captivated market attention."
      },
      {
        "title": "Neuland Laboratories Ltd Surges 7.95% to Day's High of Rs 21,850 — Outperforms Sector by 6.96 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-hits-intraday-high-with-795-surge-on-6-august-2026-4139841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NeulandLaborato_priceRelatedfactors_4139841.png",
        "date": "2026-08-06 09:47:04",
        "description": "The Sensex edged up 0.23% on 6 Aug 2026, while Neuland Laboratories Ltd surged 7.95%, reaching an intraday high of Rs 21,850. This 6.96-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift."
      },
      {
        "title": "Neuland Laboratories Ltd Opens 6.54% Higher in Sharp Gap Up, But Can the Technicals Support It?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/neuland-laboratories-ltd-opens-with-strong-gap-up-reflecting-positive-market-sentiment-4139828",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NeulandLaborato_gapup_4139828.png",
        "date": "2026-08-06 09:45:17",
        "description": ""
      }
    ],
    "total": 799,
    "sid": "229993",
    "stock_news_url": "https://www.marketsmojo.com/news/neuland-laboratories-229993"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "07-Aug-2026",
      "details": "Intimation about Schedule of Analyst / Institutional Investor Meeting on August 12 2026",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Aug-2026",
      "details": "Copy of Newspaper Publication",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Unaudited Financial Results Of The Company For The Quarter Ended June 30 2026",
      "datetime": "05-Aug-2026",
      "details": "Unaudited Financial Results of the Company for the quarter ended June 30 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has declared <strong>340%</strong> dividend, ex-date: 24 Jul 26",
          "dt": "2026-07-24",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Neuland Laboratories Ltd has announced <strong>4:25</strong> rights issue, ex-date: 13 Aug 14",
          "dt": "2014-08-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Neuland Laboratories Surges 19.80%: 5 Key Drivers Behind the Rally

2026-08-09 13:00:07

Key Events This Week

3 Aug: Stock opens strong at Rs.19,610.60 (+2.85%)

5 Aug: New 52-week and all-time high at Rs.20,052; spectacular Q1 FY27 results announced

6 Aug: Hits new 52-week and all-time high of Rs.21,850 with a 7.95% surge and gap up opening

7 Aug: Reaches new 52-week high of Rs.22,499.95, closing at Rs.22,843.55 (+6.25%)

Week Open

Rs.19,067.60

Read full news article

Broad-Based Technical Strength Lifts Neuland Laboratories Ltd to 52-Week High of Rs 22499.95

2026-08-07 12:35:11

Surging past its previous peaks, Neuland Laboratories Ltd touched an all-time high of Rs 22,499.95 on 7 Aug 2026, marking a remarkable 74.61% gain over the past year. This rally is underpinned by a confluence of strong technical indicators and sustained price momentum, even as the broader Sensex trades lower.

Read full news article

Neuland Laboratories Ltd Hits All-Time High of Rs 22,447 as Momentum Builds Across Timeframes

2026-08-07 12:15:44

Read full news article

Neuland Laboratories Ltd is Rated Buy

2026-08-07 10:10:03

Neuland Laboratories Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 07 August 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

Are Neuland Laboratories Ltd latest results good or bad?

2026-08-06 19:21:15

Neuland Laboratories Ltd's latest financial results for Q1 FY27 reflect a complex operational landscape. The company reported net sales of ₹641.58 crores, marking a significant year-on-year growth of 119.16% from a low base in Q1 FY26. However, this growth is tempered by a sequential decline of 17.35% from the previous quarter, indicating volatility in revenue generation. Net profit for the quarter stood at ₹147.67 crores, which represents an impressive year-on-year increase of 962.37%. Nevertheless, this figure also reflects a decrease of 30.56% compared to Q4 FY26, raising questions about the sustainability of such high profitability levels. The operating margin for Q1 FY27 was reported at 34.74%, a substantial increase from 11.78% in the same quarter last year, but a decline from 39.59% in the prior quarter, suggesting challenges in maintaining margin levels. The company's return on equity (ROE) is no...

Read full news article

Neuland Laboratories Ltd Surges on High-Value Trading and Institutional Interest

2026-08-06 10:00:08

Neuland Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable surge in trading activity on 6 August 2026, driven by substantial value turnover and heightened institutional participation. The stock outperformed its sector peers and broader market indices, reflecting renewed investor confidence and robust market dynamics.

Read full news article

Broad-Based Technical Strength Lifts Neuland Laboratories Ltd to 52-Week High of Rs 21850

2026-08-06 09:54:45

Surging past its previous peaks, Neuland Laboratories Ltd touched a new 52-week high of Rs 21,850 on 6 Aug 2026, propelled by a confluence of robust technical indicators and sustained price momentum that has captivated market attention.

Read full news article

Neuland Laboratories Ltd Surges 7.95% to Day's High of Rs 21,850 — Outperforms Sector by 6.96 Percentage Points

2026-08-06 09:47:04

The Sensex edged up 0.23% on 6 Aug 2026, while Neuland Laboratories Ltd surged 7.95%, reaching an intraday high of Rs 21,850. This 6.96-percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market lift.